Key result
Intravenous administration of 0.2 mg methylergonovine during a Cesarean section induced sudden maternal cardiac arrest, which was successfully reversed with prompt cardiopulmonary resuscitation.
Case Report (n=1)
No
Intravenous methylergonovine can precipitate life-threatening coronary artery spasm and cardiac arrest in postpartum patients, requiring prompt recognition and resuscitation.
Answers are grounded in this paper and cite their sources.
Clinicians should recognize IV methylergonovine as a potential arrest trigger in cesarean delivery; single case leaves open incidence and alternatives.
Methylergonovine is commonly used for the prevention and treatment of postpartum hemorrhage, which promotes contractions of uterine and vascular smooth muscles.However, this drug precipitates serious cardiac complications such as ischemic heart disease, acute myocardial infarction and cardiac arrest in some patients as a consequence of coronary artery spasm.Cardiac complication of methylergonovine is often overlooked by an obstetrician because the frequency of this is very low during postpartum.We report a case of maternal cardiac arrest induced by intravenous methylergonovine which was recovered by prompt cardiac resuscitation and adequate medical treatment during Cesarean section of triplet pregnancy.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2012) conducted a case report in Triplet pregnancy undergoing Cesarean section (n=1). Methylergonovine was evaluated on Cardiac arrest. Intravenous administration of 0.2 mg methylergonovine during a Cesarean section induced sudden maternal cardiac arrest, which was successfully reversed with prompt cardiopulmonary resuscitation.
Synapse has enriched 10 related papers. Consider them for comparative context: